{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T12:46:08Z","timestamp":1768567568860,"version":"3.49.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,15]]},"DOI":"10.7759\/cureus.50579","type":"journal-article","created":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T15:31:50Z","timestamp":1702654310000},"source":"Crossref","is-referenced-by-count":1,"title":["Long-Term Clinical Outcome of Tacrolimus Skin Ointment (0.03%) for the Treatment of Vernal Keratoconjunctivitis: A Quasi-Experimental Study"],"prefix":"10.7759","author":[{"given":"Warda","family":"Ali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saad","family":"Alam khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fahim","family":"Ullah Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shama","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wajid A","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rabeeah","family":"Zafar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad A","family":"Moqeet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.5935\/0004-2749.20170038","article-title":"Tacrolimus eye drops as monotherapy for vernal keratoconjunctivitis: a randomized controlled trial","volume":"80","author":"M\u00fcller EG","year":"2017","unstructured":"M\u00fcller EG, Santos MS, Freitas D, Gomes J\u00c1P, Belfort R Jr. Tacrolimus eye drops as monotherapy for vernal keratoconjunctivitis: a randomized controlled trial. Arq Bras Oftalmol. 2017, 80:154-8. 10.5935\/0004-2749.20170038","journal-title":"Arq Bras Oftalmol"},{"key":"ref2","article-title":"To assess the efficacy and safety of tacrolimus skin cream, 0.03% in moderate to severe vernal keratoconjunctivitis","author":"Irfan S","unstructured":"Irfan S, Ahmed A, Pak R. To assess the efficacy and safety of tacrolimus skin cream, 0.03% in moderate to severe vernal keratoconjunctivitis. Pak J Ophthalmol.","journal-title":"Pak J Ophthalmol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.882240","article-title":"Diagnosis, management, and treatment of vernal keratoconjunctivitis in asia: recommendations from the management of vernal keratoconjunctivitis in Asia Expert Working Group","volume":"9","author":"Mehta JS","year":"2022","unstructured":"Mehta JS, Chen WL, Cheng AC, et al.. Diagnosis, management, and treatment of vernal keratoconjunctivitis in asia: recommendations from the management of vernal keratoconjunctivitis in Asia Expert Working Group. Front Med (Lausanne). 2022, 9:10.3389\/fmed.2022.882240","journal-title":"Front Med (Lausanne)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2332\/allergolint.55.121","article-title":"Fibroblasts as local immune modulators in ocular allergic disease","volume":"55","author":"Fukuda K","year":"2006","unstructured":"Fukuda K, Kumagai N, Fujitsu Y, Nishida T. Fibroblasts as local immune modulators in ocular allergic disease. Allergol Int. 2006, 55:121-9. 10.2332\/allergolint.55.121","journal-title":"Allergol Int"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2005.09.002","article-title":"Role of structural cells of the cornea and conjunctiva in the pathogenesis of vernal keratoconjunctivitis","volume":"25","author":"Kumagai N","year":"2006","unstructured":"Kumagai N, Fukuda K, Fujitsu Y, Yamamoto K, Nishida T. Role of structural cells of the cornea and conjunctiva in the pathogenesis of vernal keratoconjunctivitis. Prog Retin Eye Res. 2006, 25:165-87. 10.1016\/j.preteyeres.2005.09.002","journal-title":"Prog Retin Eye Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/1824-7288-39-18","article-title":"Allergic conjunctivitis: a comprehensive review of the literature","volume":"39","author":"La Rosa M","year":"2013","unstructured":"La Rosa M, Lionetti E, Reibaldi M, et al.. Allergic conjunctivitis: a comprehensive review of the literature. Ital J Pediatr. 2013, 39:18. 10.1186\/1824-7288-39-18","journal-title":"Ital J Pediatr"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.sjopt.2019.04.001","article-title":"Therapeutic effects of topical 0.03% Tacrolimus ointment in children with refractory vernal keratoconjunctivitis in Middle East","volume":"33","author":"Fiorentini SF","year":"2019","unstructured":"Fiorentini SF, Khurram D. Therapeutic effects of topical 0.03% Tacrolimus ointment in children with refractory vernal keratoconjunctivitis in Middle East. Saudi J Ophthalmol. 2019, 33:117-20. 10.1016\/j.sjopt.2019.04.001","journal-title":"Saudi J Ophthalmol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s40123-013-0019-y","article-title":"Management of vernal keratoconjunctivitis","volume":"2","author":"Leonardi A","year":"2013","unstructured":"Leonardi A. Management of vernal keratoconjunctivitis. Ophthalmol Ther. 2013, 2:73-88. 10.1007\/s40123-013-0019-y","journal-title":"Ophthalmol Ther"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Vernal keratoconjunctivitis - EyeWiki. Accessed. August 21, 2021: https:\/\/eyewiki.aao.org\/Vernal_Keratoconjunctivitis.","DOI":"10.1097\/ACI.0000000000000765"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4103\/0301-4738.179727","article-title":"Systematic approach to managing vernal keratoconjunctivitis in clinical practice: Severity grading system and a treatment algorithm","volume":"64","author":"Gokhale NS","year":"2016","unstructured":"Gokhale NS. Systematic approach to managing vernal keratoconjunctivitis in clinical practice: Severity grading system and a treatment algorithm. Indian J Ophthalmol. 2016, 64:145-8. 10.4103\/0301-4738.179727","journal-title":"Indian J Ophthalmol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/ACI.0b013e3282efb726","article-title":"Clinical grading of vernal keratoconjunctivitis","volume":"7","author":"Bonini S","year":"2007","unstructured":"Bonini S, Sacchetti M, Mantelli F, Lambiase A. Clinical grading of vernal keratoconjunctivitis. Curr Opin Allergy Clin Immunol. 2007, 7:436-41. 10.1097\/ACI.0b013e3282efb726","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/all.13786","article-title":"Management of ocular allergy","volume":"74","author":"Leonardi A","year":"2019","unstructured":"Leonardi A, Silva D, Perez Formigo D, et al.. Management of ocular allergy. Allergy. 2019, 74:1611-30. 10.1111\/all.13786","journal-title":"Allergy"},{"key":"ref13","article-title":"Vernal keratoconjunctivitis","author":"Kaur K","year":"2023","unstructured":"Kaur K, Gurnani B. Vernal keratoconjunctivitis. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2023."},{"key":"ref14","doi-asserted-by":"crossref","DOI":"10.1097\/00055735-200012000-00016","article-title":"Ocular complications of topical, peri-ocular, and systemic corticosteroids","volume":"11","author":"Carnahan M","year":"2000","unstructured":"Carnahan M, Goldstein D. Ocular complications of topical, peri-ocular, and systemic corticosteroids. Curr Opin Ophthalmol. 2000, 11:478-83.","journal-title":"Curr Opin Ophthalmol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2011.75","article-title":"Topical 0.005% tacrolimus eye drop for refractory vernal keratoconjunctivitis","volume":"25","author":"Kheirkhah A","year":"2011","unstructured":"Kheirkhah A, Zavareh MK, Farzbod F, Mahbod M, Behrouz MJ. Topical 0.005% tacrolimus eye drop for refractory vernal keratoconjunctivitis. Eye (Lond). 2011, 25:872-80. 10.1038\/eye.2011.75","journal-title":"Eye (Lond)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.7164\/antibiotics.40.1249","article-title":"FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics","volume":"40","author":"Kino T","year":"1987","unstructured":"Kino T, Hatanaka H, Hashimoto M, et al.. FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics. J Antibiot (Tokyo). 1987, 40:1249-55. 10.7164\/antibiotics.40.1249","journal-title":"J Antibiot (Tokyo)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.4103\/0974-9233.164616","article-title":"Tacrolimus ointment for treatment of vernal keratoconjunctivitis","volume":"23","author":"Al-Amri AM","year":"2016","unstructured":"Al-Amri AM, Mirza AG, Al-Hakami AM. Tacrolimus ointment for treatment of vernal keratoconjunctivitis. Middle East Afr J Ophthalmol. 2016, 23:135-8. 10.4103\/0974-9233.164616","journal-title":"Middle East Afr J Ophthalmol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0420.2006.00699.x","article-title":"Effect of 0.03% tacrolimus ointment on conjunctival cytology in patients with severe atopic blepharoconjunctivitis: a retrospective study","volume":"84","author":"Virtanen HM","year":"2006","unstructured":"Virtanen HM, Reitamo S, Kari M, Kari O. Effect of 0.03% tacrolimus ointment on conjunctival cytology in patients with severe atopic blepharoconjunctivitis: a retrospective study. Acta Ophthalmol Scand. 2006, 84:693-5. 10.1111\/j.1600-0420.2006.00699.x","journal-title":"Acta Ophthalmol Scand"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.2165\/11587010-000000000-00000","article-title":"Tacrolimus in the treatment of ocular diseases","volume":"25","author":"Zhai J","year":"2011","unstructured":"Zhai J, Gu J, Yuan J, Chen J. Tacrolimus in the treatment of ocular diseases. BioDrugs. 2011, 25:89-103. 10.2165\/11587010-000000000-00000","journal-title":"BioDrugs"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/01.ico.0000151507.49565.6e","article-title":"Topical tacrolimus ointment for treatment of refractory anterior segment inflammatory disorders","volume":"24","author":"Joseph MA","year":"2005","unstructured":"Joseph MA, Kaufman HE, Insler M. Topical tacrolimus ointment for treatment of refractory anterior segment inflammatory disorders. Cornea. 2005, 24:417-20. 10.1097\/01.ico.0000151507.49565.6e","journal-title":"Cornea"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.2332\/allergolint.09-OA-0100","article-title":"Evaluation of novel scoring system named 5-5-5 exacerbation grading scale for allergic conjunctivitis disease","volume":"58","author":"Shoji J","year":"2009","unstructured":"Shoji J, Inada N, Sawa M. Evaluation of novel scoring system named 5-5-5 exacerbation grading scale for allergic conjunctivitis disease. Allergol Int. 2009, 58:591-7. 10.2332\/allergolint.09-OA-0100","journal-title":"Allergol Int"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.36351\/pjo.v35i4.872","article-title":"The efficacy of 0.03% dermatological tacrolimus ointment for refractory vernal keratoconjunctivitis","volume":"35","author":"Imtiaz HS","year":"2019","unstructured":"Imtiaz HS, Qayyum I, Iqbal U, Ali F, Sharjeel M. The efficacy of 0.03% dermatological tacrolimus ointment for refractory vernal keratoconjunctivitis. Pak J Ophthalmol. 2019, 35:229-34. 10.36351\/pjo.v35i4.872","journal-title":"Pak J Ophthalmol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.4103\/0976-9668.166051","article-title":"Efficacy of topical application of 0.03% tacrolimus eye ointment in the management of allergic conjunctivitis","volume":"6","author":"Hazarika AK","year":"2015","unstructured":"Hazarika AK, Singh PK. Efficacy of topical application of 0.03% tacrolimus eye ointment in the management of allergic conjunctivitis. J Nat Sci Biol Med. 2015, 6:S10-2. 10.4103\/0976-9668.166051","journal-title":"J Nat Sci Biol Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-019-04287-1","article-title":"Dermatologic tacrolimus ointment on the eyelids for steroid-refractory vernal keratoconjunctivitis","volume":"257","author":"Liu FY","year":"2019","unstructured":"Liu FY, Liu HY, Chu HS, Chen WL, Hu FR, Wang IJ. Dermatologic tacrolimus ointment on the eyelids for steroid-refractory vernal keratoconjunctivitis. Graefes Arch Clin Exp Ophthalmol. 2019, 257:967-74. 10.1007\/s00417-019-04287-1","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3341\/kjo.2012.26.4.241","article-title":"Therapeutic effect of 0.03% tacrolimus ointment for ocular graft versus host disease and vernal keratoconjunctivitis","volume":"26","author":"Ryu EH","year":"2012","unstructured":"Ryu EH, Kim JM, Laddha PM, Chung ES, Chung TY. Therapeutic effect of 0.03% tacrolimus ointment for ocular graft versus host disease and vernal keratoconjunctivitis. Korean J Ophthalmol. 2012, 26:241-7. 10.3341\/kjo.2012.26.4.241","journal-title":"Korean J Ophthalmol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtos.2019.07.004","article-title":"Adult vernal keratoconjunctivitis: clinical and biochemical profile of a rare disease","volume":"17","author":"Di Zazzo A","year":"2019","unstructured":"Di Zazzo A, Micera A, De Piano M, Coassin M, Sharma S, Bonini S, Fernandes M. Adult vernal keratoconjunctivitis: clinical and biochemical profile of a rare disease. Ocul Surf. 2019, 17:737-42. 10.1016\/j.jtos.2019.07.004","journal-title":"Ocul Surf"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2013-304453","article-title":"Therapeutic effects of 0.1% tacrolimus eye drops for refractory allergic ocular diseases with proliferative lesion or corneal involvement","volume":"98","author":"Fukushima A","year":"2014","unstructured":"Fukushima A, Ohashi Y, Ebihara N, et al.. Therapeutic effects of 0.1% tacrolimus eye drops for refractory allergic ocular diseases with proliferative lesion or corneal involvement. Br J Ophthalmol. 2014, 98:1023-7. 10.1136\/bjophthalmol-2013-304453","journal-title":"Br J Ophthalmol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1080\/02713683.2019.1600197","article-title":"Topical tacrolimus for chronic allergic conjunctival disease with and without atopic dermatitis","volume":"44","author":"Shoji J","year":"2019","unstructured":"Shoji J, Ohashi Y, Fukushima A, et al.. Topical tacrolimus for chronic allergic conjunctival disease with and without atopic dermatitis. Curr Eye Res. 2019, 44:796-805. 10.1080\/02713683.2019.1600197","journal-title":"Curr Eye Res"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1186\/s13223-021-00513-w","article-title":"Long-term outcomes of 0.1% tacrolimus eye drops in eyes with severe allergic conjunctival diseases","volume":"17","author":"Yazu H","year":"2021","unstructured":"Yazu H, Fukagawa K, Shimizu E, Sato Y, Fujishima H. Long-term outcomes of 0.1% tacrolimus eye drops in eyes with severe allergic conjunctival diseases. Allergy Asthma Clin Immunol. 2021, 17:11. 10.1186\/s13223-021-00513-w","journal-title":"Allergy Asthma Clin Immunol"},{"key":"ref30","article-title":"Efficacy and safety of low-dose topical tacrolimus in vernal keratoconjunctivitis","volume":"7","author":"Shoughy SS","year":"2016","unstructured":"Shoughy SS, Jaroudi MO, Tabbara KF. Efficacy and safety of low-dose topical tacrolimus in vernal keratoconjunctivitis. Clin Ophthalmol. 2016, 7:643-7.","journal-title":"Clin Ophthalmol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/209816-long-term-clinical-outcome-of-tacrolimus-skin-ointment-003-for-the-treatment-of-vernal-keratoconjunctivitis-a-quasi-experimental-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:09:37Z","timestamp":1707509377000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/209816-long-term-clinical-outcome-of-tacrolimus-skin-ointment-003-for-the-treatment-of-vernal-keratoconjunctivitis-a-quasi-experimental-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,15]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.50579","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12,15]]}}}